Evolution of the Average Target: Medifast, Inc.

Evolution of the Target Price: Medifast, Inc.

Changes in Analyst Recommendations: Medifast, Inc.

2ecd703d8b2a293454bd9b951fc.Gp0xpbH3hI0WRlrIh8PI-YmxZeYARH3LYht1CVrFC4w.TKpL6-LA_M97MWisz_CCluGDNtBUDgi4IXAfYxXzeN97x0vn95Ps_HMZbg~1aa4cced76f05b64aeecb925d9582bf6
24-06-05 DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target MT
23-10-13 Stephens Initiates Medifast With Equalweight Rating, Price Target is $82 MT
23-07-31 DA Davidson Adjusts Medifast Price Target to $93 From $75, Maintains Neutral Rating MT
23-06-22 DA Davidson Adjusts Medifast Price Target to $75 From $71, Maintains Neutral Rating MT
23-05-02 DA Davidson Adjusts Price Target on Medifast to $71 From $94, Maintains Neutral Rating MT
23-02-22 DA Davidson Lowers Price Target on Medifast to $94 From $106, Keeps Neutral Rating MT
22-11-04 DA Davidson Downgrades Medifast to Neutral From Buy, Adjusts Price Target to $106 From $278 MT
22-08-04 DA Davidson Cuts Medifast's Price Target to $278 From $352, Reiterates Buy Rating MT
22-08-04 Jefferies Downgrades Medifast to Hold From Buy; Price Target is $150 MT
22-06-02 DA Davidson Adjusts Medifast's Price Target to $352 From $341, Reiterates Buy Rating MT
22-02-24 DA Davidson Adjusts Medifast's Price Target to $341 from $349, Maintains Buy Rating MT
21-11-08 DA Davidson Adjusts Medifast's Price Target to $349 from $395, Keeps Buy Rating MT
21-05-05 MEDIFAST : DA Davidson Adjusts Price Target on Medifast to $395 From $302, Maintains Buy Rating MT
21-05-05 MEDIFAST : B. Riley Raises Medifast's PT to $400 from $310 After Q1 Results Top Consensus, Keeps Buy Rating MT
21-02-26 MEDIFAST : B. Riley Raises Medifast's Price Target to $310 from $300 After Q4 2020 Results Beat Estimates, Maintains Buy Rating MT
21-02-19 MEDIFAST : B. Riley Raises Medifast's Price Target to $300 From $250, Keeps Buy Rating MT
21-01-25 MEDIFAST : Jefferies Upgrades Medifast to Buy From Hold, Adjusts Price Target to $265 From $205 MT
21-01-12 MEDIFAST : DA Davidson Adjusts Medifast's Price Target to $239 from $205, Keeps Buy Rating MT
20-11-05 MEDIFAST : DA Davidson Upgrades Medifast to Buy From Neutral, Adjusts Price Target to $205 From $180 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - +11.94%
+30.69%
+26.96%
+33.49%
+8.84%
+39.42%
- - +60.7%
+10.69%
+17.46%
Average +26.69%
Weighted average by Cap. +29.09%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.72USD
Average target price
12.00USD
Spread / Average Target
+11.94%
High Price Target
12.00USD
Spread / Highest target
+11.94%
Low Price Target
12.00USD
Spread / Lowest Target
+11.94%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

DA Davidson
Stephens Inc.
Jefferies & Co.
B. Riley
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.72USD
Average target price
12.00USD
Spread / Average Target
+11.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MED Stock
  4. Consensus Medifast, Inc.